Scientists develop groundbreaking dual-action drug RI-AG03 that targets toxic tau proteins in Alzheimer's disease, showing ...

We now have a glimpse behind the curtain of how Medicare arrives at so-called maximum fair prices of prescription drugs it ...

Ovarian Cancer Targeted Medication: PARP Inhibitors, Anti-Angiogenic Drugs, Immunotherapy, and More Ovarian cancer is the malignancy with the highest rate of death from tumors of the female ...

The Amazon is renowned for its cultural diversity, particularly the ethnic diversity of its Indigenous nations, but also the ...

President Sheinbaum shared a plan to strengthen Mexico's semiconductor industry and touched on GMO corn and the U.S. DEA on ...

However, we still see areas of weakness in the portfolio, including upcoming patent losses and a highly uncertain pipeline due to the complexities of running CNS trials. Historically, the firm ...

Artificial intelligence (AI) is transforming various industries as a major investing theme in 2025. The technology's ability ...

Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers, today announced the introduction of its Gyrolab® HEK293 HCP Type SN Kit ...

In the first few days of his second presidential term, newly inaugurated President Trump signed a number of executive orders that will have an ...

Human fungal pathogens exemplify a severe threat to health due to their complex infection strategies and the host's immune system's failure to eradicate ...

In a shift away from GMOS, aka genetically modified organisms, important research is continuing in gene editing, sometimes ...

Genentech Inc. won regulatory approval Tuesday to market an eye implant that can be refilled every six months with an already ...